Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (21 items missing)
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Revenue
250
370
478
541
620
685
762
811
Cost of goods sold (excluding below amortization of intangible assets)
39
61
85
112
153
180
182
194
Gross Profit
211
309
393
428
467
505
580
617
Sales, marketing and administrative
189
255
315
349
372
420
468
465
Research and development
26
38
41
38
35
32
38
36
In-process research and development
21
0
0
0
0
0
0
0
Amortization of intangible assets
3
5
5
7
12
19
14
13
Impairment of intangible assets
0
0
0
18
10
0
11
0
Litigation liability (gain) loss
0
0
0
101
0
0
30
-42
Business transition costs
0
0
0
0
0
0
1
6
Total operating expenses
239
298
361
513
430
472
562
478
Interest income
6
2
1
1
1
1
1
2
Interest expense
-6
-7
-7
-18
-28
-27
-28
-29
Other income (expense), net
0
0
0
2
1
3
-2
0
Total interest and other expense, net
0
-5
-6
-15
-26
-23
-29
-27
INCOME (LOSS) BEFORE INCOME TAXES
-28
6
26
-100
11
10
-11
112
Income tax expense
0
2
-51
-29
-9
-3
-6
-47
Consolidated net income (loss)
-28
4
77
-71
2
7
-17
65
Add back net loss attributable to non-controlling interests
0
-1
-2
-1
-1
-1
-1
-1
Net income (loss) attributable to NuVasive, Inc.
-28
6
78
-70
3
8
-17
66
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Feb 27, 2013 n/a
calculated values,
restated on Mar 3, 2014 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Feb 11, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (47 items missing)
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash and cash equivalents
n/a
65
93
163
123
103
142
192
Short-term marketable securities
n/a
99
86
146
138
143
220
165
Accounts receivable, net of allowances of $5,320 and $5,844, respectively
n/a
58
74
88
89
105
119
128
Inventory, Net
n/a
90
108
119
126
137
155
168
Deferred tax assets
n/a
0
4
55
28
37
0
0
Prepaid income taxes
n/a
0
0
0
0
0
11
41
Prepaid expenses and other current assets
n/a
4
6
21
8
11
10
9
Total current assets
n/a
317
372
592
514
536
658
703
Property and equipment, net
n/a
83
102
125
125
128
129
141
Long-term marketable securities
n/a
40
51
33
84
80
43
112
Intangible assets, net
n/a
103
107
108
101
94
97
85
Goodwill
n/a
102
103
159
154
155
154
154
Deferred tax assets, non-current
n/a
1
52
20
41
43
111
84
Restricted cash and investments
n/a
0
6
69
119
119
123
6
Other assets
n/a
7
10
19
25
25
26
17
Total assets
n/a
653
802
1,124
1,164
1,180
1,342
1,303
Liabilities and owners' equity
Accounts payable and accrued liabilities
n/a
36 35636000
59 58995000
52 51744000
62 62048000
86 86057000
133 133324000
61 60985000
Accrued payroll and related expenses
n/a
19 19111000
17 17266000
22 22215000
28 27916000
31 31095000
38 38032000
38 37641000
Acquisition-related liabilities
n/a
0 0
33 32715000
0 0
0 0
0 0
0 0
0 0
Acquisition-related liabilities
n/a
31 30694000
0 326000
32 32221000
0 0
0 0
0 0
0 0
Senior Convertible Notes, current
n/a
0 0
0 0
0 0
74 74311000
0 0
0 0
0 0
Litigation liabilities
n/a
0 0
0 0
101 101200000
0 0
0 0
30 30000000
0 0
Income tax liabilities
n/a
0 0
0 0
0 0
0 0
0 0
13 12740000
1 990000
Total current liabilities
n/a
55 54747000
109 108976000
207 207380000
164 164275000
117 117152000
214 214096000
100 99616000
Senior convertible notes
n/a
230 230000000
230 230000000
394 394019000
332 332404000
346 346060000
361 360746000
373 372920000
Deferred and income tax liabilities, non-current
n/a
17 16756000
4 3685000
4 3952000
3 3129000
3 2934000
11 11441000
9 8602000
Non-current litigation liabilities
n/a
0 0
0 0
0 0
101 101200000
94 93700000
94 93700000
88 88261000
Other long-term liabilities
n/a
11 10772000
13 12810000
13 13461000
15 15199000
15 14844000
13 13230000
14 14425000
Commitments and contingencies
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Noncontrolling interests
n/a
14 13629000
12 11877000
11 10705000
10 10003000
0 0
0 0
0 0
Preferred stock, $0.001 par value; 5,000,000 shares authorized, none outstanding
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Common stock, $0.001 par value; 120,000,000 shares authorized at December 31, 2015 and 2014, respectively, 52,616,471 and 47,691,744 issued and outstanding at December 31, 2015 and
n/a
0 39000
0 40000
0 42000
0 44000
0 45000
0 48000
0 53000
Additional paid-in capital
n/a
486 485757000
545 545114000
675 674790000
715 714865000
769 769203000
847 847145000
989 989387000
Accumulated other comprehensive loss
n/a
0 126000
1 616000
0 477000
1 786000
-3 -3238000
-10 -9670000
-12 -12112000
Accumulated deficit
n/a
-190 -189700000
-111 -111415000
-181 -181264000
-178 -178120000
-170 -170218000
-187 -186938000
-104 -104006000
Treasury stock at cost; 3,316,794 shares and 233,369 shares at December 31, 2015 and December 31, 2014, respectively
n/a
0 0
0 0
0 0
0 0
0 0
-11 -10537000
-162 -161788000
Total NuVasive, Inc. stockholders’ equity
n/a
296 296222000
434 434355000
494 494045000
538 537575000
596 595792000
640 640048000
712 711534000
Non-controlling interests
n/a
0 0
0 0
0 0
0 0
9 9086000
8 8310000
7 7309000
Total equity
n/a
0 0
0 0
0 0
538 537575000
605 604878000
648 648358000
719 718843000
Total liabilities and equity
n/a
653 652820000
802 802029000
1,124 1123562000
1,164 1163785000
1,180 1179568000
1,342 1341571000
1,303 1302667000
Remarks restated on n/a restated on Nov 30, -1 n/a restated on Feb 27, 2012 n/a restated on Feb 27, 2013 n/a restated on Mar 3, 2014 n/a restated on Nov 30, -1 n/a restated on Feb 11, 2016 n/a restated on Jul 26, 2016 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (60 items missing)
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Consolidated net income (loss)
-28
4
77
-71
2
7
-17
65
Depreciation and amortization
23
30
37
36
52
63
66
66
Deferred income tax expense (benefit)
0
0
-54
-31
5
-11
-23
35
In-process research and development
21
0
0
0
0
0
0
0
Amortization of debt discount
0
0
0
6
0
0
0
0
Amortization of non-cash interest
0
1
1
2
15
15
16
18
Stock-based compensation
21
24
28
32
26
33
34
26
Loss on repurchase of Senior Convertible Notes, net
0
0
0
0
0
0
0
0
Gain recognized on change in fair value of derivatives
0
0
0
-2
0
0
0
0
Lease abandonment (reversal)
4
-2
0
0
0
0
0
0
Allowance for doubtful accounts and sales return reserves
1
2
-1
1
0
0
0
0
Allowance for excess and obsolete inventory, net of write-offs
-1
2
2
6
0
0
0
0
Accretion of contingent consideration
0
0
1
0
0
0
0
0
Impairment of intangible assets
0
0
0
18
10
0
11
0
Reserves on current assets
0
0
0
0
6
7
2
9
Other non-cash adjustments
0
2
4
6
7
7
13
18
Accounts receivable
-25
-8
-18
-10
-2
-17
-18
-9
Inventory
-32
-23
-19
-17
-11
-21
-21
-26
Prepaid expenses and other current assets
0
0
-2
-14
13
-4
-5
1
Accounts payable and accrued liabilities
5
6
12
-3
3
5
6
8
Accrued payroll and related expenses
5
8
-2
3
5
3
7
0
Accrued royalties
0
0
0
0
0
19
12
-46
Litigation liability
0
0
0
101
0
-8
30
-36
Income taxes
0
0
0
0
0
-2
4
-39
Net cash provided by operating activities
-5
46
66
63
130
97
116
89
Acquisitions and other investments
-41
-46
-1
-38
-11
-3
-1
-1
Purchases of intangible assets
0
0
0
-5
0
-12
0
-32
Payments of other long term liabilities
0
0
0
0
0
0
0
0
Proceeds from the sale of warrants
32
0
0
48
0
0
0
0
Purchase of convertible note hedge
0
0
0
-80
0
0
0
0
Proceeds from the issuance of convertible debt, net of issuance costs
222
0
0
391
0
0
0
0
Purchase of convertible note hedges
-46
0
0
0
0
0
0
0
Proceeds from sales of property and equipment
0
0
0
0
0
0
0
0
Purchases of property and equipment
-40
-33
-46
-53
-41
-48
-58
-76
Purchases of marketable securities
-159
-157
-203
-253
-236
-218
-217
-428
Proceeds from marketable securities
96
108
204
152
247
216
175
411
Other assets
0
0
0
0
0
0
0
0
Purchases of restricted investments
0
0
0
-5
-113
0
-4
-63
Proceeds from restricted investments
0
0
0
0
7
0
0
181
Net cash used in investing activities
-145
-128
-46
-202
-148
-65
-105
-8
Principal payment of 2013 Senior Convertible Notes
0
0
0
0
0
-74
0
0
Repurchase of 2013 Senior Convertible Notes
0
0
0
-154
0
0
0
0
Incremental tax benefits related to stock-based compensation awards
0
2
0
0
3
14
12
15
Proceeds from the issuance of common stock
12
13
15
7
5
8
23
12
Payment of contingent consideration
0
0
0
-2
-30
0
0
-1
Purchase of treasury stock
0
0
0
0
0
0
-4
-57
Other financing activities
0
0
-8
-1
-1
0
-1
0
Net cash (used in) provided by financing activities
220
14
7
210
-23
-52
30
-30
Effect of exchange rate changes on cash
0
0
0
0
0
-1
-1
-1
Increase (decrease) in cash and cash equivalents
70
-67
27
71
-40
-20
40
50
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Feb 27, 2013 n/a
calculated values,
restated on Mar 3, 2014 n/a
calculated values,
restated on Feb 25, 2015 n/a
calculated values,
restated on Feb 11, 2016 n/a
calculated values,
restated on Feb 11, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,